Emer Cooke, executive director of the EMA, said: We need to step up actions now industry, regulators, healthcare professionals, patients and the public at large all have a role to play in resolving these shortages and we are appealing to everyone to play their part. In June 2023, the UK government declared a national shortage of GLP-1 RAs for type 2 diabetes mellitus until 2024, attributing the shortages to an increase in demand for these products for licensed and off-label indications
Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review
Ozempic a diabetes medication popular among celebrities for weight loss benefits is classified as a GLP-1 agonist
This article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment
If the evaluating clinician determines that a prescription is not appropriate, the company states the patient receives a full refund minus a $39 doctor visit fee